When the Drug Supply Chain Security Act (DSCSA) was signed into law in 2013 as a way to identify and eliminate counterfeits products and improve traceability associated with recalls, the U.S. Food & Drug Administration (FDA) said that requirements would be implemented over a ten-year timeframe.
Implementation phases include: lot-level management, which started in January 2015; item serialization—to be addressed in 2017; with serialized item-level traceability to be complete by 2023, thereby allowing supply chain partners to trace the ownership back to the initial manufacturer or repackager.



















